Rare diseases
Investigational molecules
Locations
Back to Portugal679 clinical trials in Porto, Portugal across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on the Effects of Rusfertide (PTG-300) for Patients with Polycythemia Vera
PortugalStudy Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant
PortugalLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
PortugalStudy of [177Lu]Lu-NeoB and Capecitabine for Patients with Advanced Breast Cancer Resistant to Hormone Therapy
PortugalStudy of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
PortugalStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations
PortugalStudy on Atezolizumab for Patients with Non-Small Cell Lung Cancer After Chemotherapy
PortugalStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
PortugalStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
PortugalStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
PortugalStudy of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment
PortugalStudy on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on polypoidal choroidal vasculopathy and rare genetic conditions like PMM2-CDG, exploring new treatment approaches to improve patient outcomes.
Groundbreaking studies in chronic myelogenous leukemia, multiple myeloma, and advanced malignancies, including research on novel therapies for non-small cell lung cancer.
Comprehensive research into conditions like hidradenitis suppurativa, plaque psoriasis, and pyoderma gangrenosum, evaluating new therapeutic approaches.
Studies examining hypertrophic cardiomyopathy, familial hypercholesterolemia, and innovative treatments for obesity.
Investigating treatments for Dravet Syndrome, menstrual migraine, and rare conditions like Niemann-Pick disease.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
